Deleting, down-regulating or blocking of FcγRIIB modifies immune responses during both steady state and infection, with FcγRIIB deficiency contributing to a number of pathologies [14, 15, 18, 26–32, 35, 37, 40]. This evidence concerns the gene FCGR2B and infection.